Conway Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Conway Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$149K	Hold	10,000	–	–	0.07%	44
2025 Q4	$250K	Hold	10,000	–	–	0.11%	40
2025 Q3	$97.9K	Hold	10,000	–	–	0.04%	49
2025 Q2	$42.6K	Hold	10,000	–	–	0.02%	49
2025 Q1	$37.6K	Hold	10,000	–	–	0.02%	43
2024 Q4	$58.3K	Hold	10,000	–	–	0.03%	48
2024 Q3	$119K	Hold	10,000	–	–	0.06%	47
2024 Q2	$108K	Hold	10,000	–	–	0.05%	41
2024 Q1	$113K	Sell	10,000 -16,500	-62%	-$213K	0.06%	45
2023 Q4	$372K	Hold	26,500	–	–	0.24%	34
2023 Q3	$327K	Hold	26,500	–	–	0.24%	31
2023 Q2	$239K	Hold	26,500	–	–	0.17%	41
2023 Q1	$92K	Hold	26,500	–	–	0.08%	46
2022 Q4	$64.9K	Hold	26,500	–	–	0.07%	43
2022 Q3	$73.1K	Hold	26,500	–	–	0.07%	48
2022 Q2	$108K	Hold	26,500	–	–	0.1%	47
2022 Q1	$113K	Sell	26,500 -5,774	-18%	-$31.8K	0.07%	57
2021 Q4	$302K	Hold	32,274	–	–	0.18%	46
2021 Q3	$889K	Sell	32,274 -10,000	-24%	-$270K	0.6%	31
2021 Q2	$1.18M	Buy	+42,274	New	+$1.2M	0.81%	29

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Conway Capital Management's OLMA Position: Q1 2026 in Review

Conway Capital Management held its Olema Pharmaceuticals (OLMA) position steady in Q1 2026 at 10,000 shares worth $149K. The position accounts for 0.07% of the portfolio, ranked #44.

Conway Capital Management first reported a position in OLMA in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.18M in Q2 2021. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

Conway Capital Management held 10,000 shares of Olema Pharmaceuticals worth $149K as of Q1 2026.
Conway Capital Management left its Olema Pharmaceuticals share count unchanged in Q1 2026.
Olema Pharmaceuticals made up 0.07% of Conway Capital Management's portfolio in Q1 2026, its #44 holding.
Conway Capital Management first reported a position in Olema Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
Conway Capital Management's Olema Pharmaceuticals position peaked at $1.18M in Q2 2021.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Conway Capital Management's 13F filing for Q1 2026, filed 7 May 2026.